Login to Your Account



Other News To Note


Wednesday, September 14, 2011

Aduro BioTech Inc., of Berkeley, Calif., has received three grants relating to its Listeria monocytogenes vaccine platform. The grants from the Defense Threat Reduction Agency and the National Institutes of Health will support development of vaccines for tularemia, hepatitis B and melanoma.

• Aduro BioTech Inc., of Berkeley, Calif., has received three grants relating to its Listeria monocytogenes vaccine platform.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription